Journal of Ultrasound in Medicine & Biology

RNS Number : 8492X
Tristel PLC
27 February 2017
 

 

Tristel plc

("Tristel" or the "Company")

 

Tristel's Wipes and foam disinfectants included in Journal of Ultrasound in Medicine & Biology

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that the World Federation for Ultrasound in Medicine & Biology has provided guidance to healthcare organisations worldwide regarding the safe and effective cleaning and disinfection of transvaginal and transrectal ultrasound probes.

 

The Technical Note identifies various high-level disinfectants that are recommended by ultrasound manufacturers and comments that Tristel's chlorine dioxide is being used extensively in the United Kingdom and Australia.  Both the Trio Wipes System and the Duo Foam product are named. Tristel is pursuing a regulatory approval from the United States Food and Drug Administration (FDA) for the Duo Foam.  

 

The Technical Note concludes that disinfection of the ultrasound probe is mandatory.  However, in many countries probes are not disinfected even though the probe is used in gynaecological procedures where there is a proven high risk of contamination of the instrument by pathogens such as human immunodeficiency virus (HIV) and human papillomavirus (HPV).  HPV is proven to be the main causal agent for cervical cancer. In addition, specific concerns include gonorrhoea and syphilis for vaginal probes and Clostridium difficile for transrectal probes. 

 

The study has been published as a Technical Note in the Journal of Ultrasound in Medicine & Biology

[Abramovich, J. S., Evans, D. H., Fowlkes, J. B., Marsal, K., terHaar, G. 'Guidelines for Cleaning Transvaginal Ultrasound Transducers Between Patients', (2017). DOI: 10.1016/j.ultrasmedbio.2017.01.002].

 

Paul Swinney, CEO of Tristel plc, comments: "Ultrasound scans in women's health are one of the world's most commonplace diagnostic procedures. It is astounding that so many of these procedures are undertaken without the instrument being properly disinfected between patients. Our Trio and Duo products are two of very few disinfectant products that are designed specifically for women's health.  Guidance such as this from the World Federation can only encourage patients to demand that the instrument being used on them is safe because it has been properly disinfected."

 

For further information please contact:

 

Tristel plc

www.tristel.com

Paul Swinney, Chief Executive 

Tel: 01638 721 500

Liz Dixon, Finance Director

 

 

 

finnCap

 

Geoff Nash / Giles Rolls, Corporate Finance

Tel: 020 7220 0500

Alice Lane, Corporate Broking

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALLFLDFVISFID

Companies

Tristel (TSTL)
UK 100

Latest directors dealings